|
SLC25A36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7098544802252E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66955338443131E-12 |
| Normal-vs-Stage2 |
5.6370000001138E-07 |
| Normal-vs-Stage3 |
2.36279884546775E-11 |
| Normal-vs-Stage4 |
6.24810000404707E-08 |
| Stage1-vs-Stage2 |
9.089800E-01 |
| Stage1-vs-Stage3 |
1.387750E-01 |
| Stage1-vs-Stage4 |
2.922200E-01 |
| Stage2-vs-Stage3 |
2.914400E-01 |
| Stage2-vs-Stage4 |
3.494000E-01 |
| Stage3-vs-Stage4 |
9.135000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74416037168612E-13 |
| Normal-vs-AfricanAmerican |
8.354500E-04 |
| Normal-vs-Asian |
4.95420000024005E-07 |
| Caucasian-vs-AfricanAmerican |
3.303600E-01 |
| Caucasian-vs-Asian |
3.769800E-01 |
| AfricanAmerican-vs-Asian |
7.950600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2662000004624E-07 |
| Normal-vs-Female |
1.62558855265615E-12 |
| Male-vs-Female |
5.442300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.14640519299769E-11 |
| Normal-vs-Age(41-60Yrs) |
8.87345752431656E-12 |
| Normal-vs-Age(61-80Yrs) |
5.5862999781553E-09 |
| Normal-vs-Age(81-100Yrs) |
1.260340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.550000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.157400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.381200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.190000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.739800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.216200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.77989999966744E-07 |
| Classical-VS-Follicular |
1.504820E-01 |
| Classical-VS-Other |
2.058600E-01 |
| Classical-VS-Normal |
4.18975965033042E-12 |
| Tall-VS-Follicular |
3.53959999976894E-07 |
| Tall-VS-Other |
6.485700E-02 |
| Tall-VS-Normal |
7.32747196252603E-15 |
| Follicular-VS-Other |
4.972200E-01 |
| Follicular-VS-Normal |
2.9997999999587E-06 |
| Other-VS-Normal |
1.648780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.92109702882249E-11 |
| Normal-vs-N1 |
2.00959999999695E-05 |
| N0-vs-N1 |
7.385000E-01 |
|
|
